Company / Cash per Share
Sonoma Pharmaceuticals, Inc. Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$6.89
FY2025
5-year range
$0.63 / $6.89
FY2021-FY2025
Trend
+986.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +986% YoY in FY2025, a notable deviation from the 8-year average annual change of +153%.
Based on SEC 10-K filings.
6.89 in FY2025 with a 5-year CAGR of +19.7%.
Improved from $1.23 to $6.89 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +24.9%
- 5-Year CAGR
- +19.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 986.1% year-over-year.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $6.89 | +986.1% |
| FY2024 | $0.63 | -48.5% |
| FY2023 | $1.23 | -65.1% |
| FY2022 | $3.53 | +70.2% |
| FY2021 | $2.08 | -25.9% |
| FY2020 | $2.80 | -80.9% |
| FY2019 | $14.68 | +260.6% |
| FY2018 | $4.07 | +128.7% |
| FY2017 | $1.78 | +336.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026